chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Inappropriate schedule of product administration, Influenza like illness
Clinical narrative: Felt like full blown flu symptoms after second shot; First dose taken on 21-Jan-2021 and second dose taken on 8-Feb-2021; A little sore arm after the second shot; This case was received via Regulatory Authority (Reference number: US-irms-MOD21-127079   ) on 05-Aug-2021 and was forwarded to Moderna on 05-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like full blown flu symptoms after second shot), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose taken on 21-Jan-2021 and second dose taken on 8-Feb-2021) and ARTHRALGIA (A little sore arm after the second shot) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 020L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like full blown flu symptoms after second shot) and ARTHRALGIA (A little sore arm after the second shot). 08-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose taken on 21-Jan-2021 and second dose taken on 8-Feb-2021). On 08-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose taken on 21-Jan-2021 and second dose taken on 8-Feb-2021) had resolved. On 11-Feb-2021, INFLUENZA LIKE ILLNESS (Felt like full blown flu symptoms after second shot) and ARTHRALGIA (A little sore arm after the second shot) had resolved.            No concomitant medications were provided.  No Treatment medications were provided.  The action taken with mRNA with the events was considered as not applicable.   This case was linked to MOD-2021-278770 (Patient Link).
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17.5 year old received vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17.5 year old received vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17.5 year old received vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17.5 year old received vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose, Device connection issue
Clinical narrative: A syringe leaked, disassembling from the needle while being used to administer the first dose of the Moderna COVID-19 vaccine  to a patient; more than half of the dose being administered while the rest leaked; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (A syringe leaked, disassembling from the needle while being used to administer the first dose of the Moderna COVID-19 vaccine  to a patient) and ACCIDENTAL OVERDOSE (more than half of the dose being administered while the rest leaked) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced DEVICE CONNECTION ISSUE (A syringe leaked, disassembling from the needle while being used to administer the first dose of the Moderna COVID-19 vaccine  to a patient) and ACCIDENTAL OVERDOSE (more than half of the dose being administered while the rest leaked). At the time of the report, DEVICE CONNECTION ISSUE (A syringe leaked, disassembling from the needle while being used to administer the first dose of the Moderna COVID-19 vaccine  to a patient) and ACCIDENTAL OVERDOSE (more than half of the dose being administered while the rest leaked) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment information was reported.  Treatment information was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Fatigue, Nausea
Clinical narrative: it could be arthritis that after the shot it became more; joint pain; nausea; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (it could be arthritis that after the shot it became more), ARTHRALGIA (joint pain), NAUSEA (nausea) and FATIGUE (extremely tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Sick for 13 days. She could not even drink a glass of water.) in February 2020. Concurrent medical conditions included Arthritis.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (it could be arthritis that after the shot it became more), ARTHRALGIA (joint pain), NAUSEA (nausea) and FATIGUE (extremely tired). At the time of the report, ARTHRITIS (it could be arthritis that after the shot it became more) and ARTHRALGIA (joint pain) had not resolved and NAUSEA (nausea) and FATIGUE (extremely tired) had resolved.            Concomitant medication was not provided. Treatment medication was provided.   This case was linked to MOD-2021-059746 (Patient Link).
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: received two doses of Pfizer's and yesterday received Moderna vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (received two doses of Pfizer's and yesterday received Moderna vaccine) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received two doses of Pfizer's and yesterday received Moderna vaccine). On 04-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (received two doses of Pfizer's and yesterday received Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Aphonia, Body temperature, Cough, Headache
Clinical narrative: lost sense of smell; lost voice; sore throat; sleeping 14-16 hours a day; Was coughing so hard that she was peeing her self; headache; coughing up a lot of  thick mucus; fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing up a lot of  thick mucus), ANOSMIA (lost sense of smell), APHONIA (lost voice), OROPHARYNGEAL PAIN (sore throat) and SOMNOLENCE (sleeping 14-16 hours a day) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (She had COVID-19 in January). Concomitant products included CLONAZEPAM for an unknown indication.    On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Aug-2021, the patient experienced COUGH (coughing up a lot of  thick mucus) and PYREXIA (fever). On an unknown date, the patient experienced ANOSMIA (lost sense of smell), APHONIA (lost voice), OROPHARYNGEAL PAIN (sore throat), SOMNOLENCE (sleeping 14-16 hours a day), URINARY INCONTINENCE (Was coughing so hard that she was peeing her self) and HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID (BABY ASPIRIN) ongoing since an unknown date for Fever, at a dose of 1 UNK. At the time of the report, COUGH (coughing up a lot of  thick mucus), ANOSMIA (lost sense of smell), APHONIA (lost voice), OROPHARYNGEAL PAIN (sore throat), SOMNOLENCE (sleeping 14-16 hours a day), URINARY INCONTINENCE (Was coughing so hard that she was peeing her self), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Aug-2021, Body temperature: 101 (High) had a fever of 101 and was coughing up a lot of thick mucus. On 02-Aug-2021, Body temperature: 102 (High) still had a fever of 101/102. On 04-Aug-2021, Body temperature: 101.1 (High) had a fever of 100.1..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       .
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Somnolence, Urinary incontinence
Clinical narrative: lost sense of smell; lost voice; sore throat; sleeping 14-16 hours a day; Was coughing so hard that she was peeing her self; headache; coughing up a lot of  thick mucus; fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing up a lot of  thick mucus), ANOSMIA (lost sense of smell), APHONIA (lost voice), OROPHARYNGEAL PAIN (sore throat) and SOMNOLENCE (sleeping 14-16 hours a day) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (She had COVID-19 in January). Concomitant products included CLONAZEPAM for an unknown indication.    On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Aug-2021, the patient experienced COUGH (coughing up a lot of  thick mucus) and PYREXIA (fever). On an unknown date, the patient experienced ANOSMIA (lost sense of smell), APHONIA (lost voice), OROPHARYNGEAL PAIN (sore throat), SOMNOLENCE (sleeping 14-16 hours a day), URINARY INCONTINENCE (Was coughing so hard that she was peeing her self) and HEADACHE (headache). The patient was treated with ACETYLSALICYLIC ACID (BABY ASPIRIN) ongoing since an unknown date for Fever, at a dose of 1 UNK. At the time of the report, COUGH (coughing up a lot of  thick mucus), ANOSMIA (lost sense of smell), APHONIA (lost voice), OROPHARYNGEAL PAIN (sore throat), SOMNOLENCE (sleeping 14-16 hours a day), URINARY INCONTINENCE (Was coughing so hard that she was peeing her self), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Aug-2021, Body temperature: 101 (High) had a fever of 101 and was coughing up a lot of thick mucus. On 02-Aug-2021, Body temperature: 102 (High) still had a fever of 101/102. On 04-Aug-2021, Body temperature: 101.1 (High) had a fever of 100.1..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       .
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Malaise, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling really crappy), COUGH (coughing), HEADACHE (residual head ache), MYALGIA (body aches) and PYREXIA (fever (it got up to 101)) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006D21A and 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) for an unknown indication. On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (feeling really crappy), COUGH (coughing), HEADACHE (residual head ache), MYALGIA (body aches), PYREXIA (fever (it got up to 101) and CHILLS (chills). At the time of the report, MALAISE (feeling really crappy), COUGH (coughing), HEADACHE (residual head ache), MYALGIA (body aches), PYREXIA (fever (it got up to 101) and CHILLS (chills) outcome was unknown. No treatment medications were provided by the reporter
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling really crappy), COUGH (coughing), HEADACHE (residual head ache), MYALGIA (body aches) and PYREXIA (fever (it got up to 101)) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006D21A and 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was reported. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) for an unknown indication. On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (feeling really crappy), COUGH (coughing), HEADACHE (residual head ache), MYALGIA (body aches), PYREXIA (fever (it got up to 101) and CHILLS (chills). At the time of the report, MALAISE (feeling really crappy), COUGH (coughing), HEADACHE (residual head ache), MYALGIA (body aches), PYREXIA (fever (it got up to 101) and CHILLS (chills) outcome was unknown. No treatment medications were provided by the reporter
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Fatigue, Pruritus
Clinical narrative: Pain in my left ovary which is chronic and getting worse; Itchy arm for a week; Fatigue for a month; This spontaneous case was reported by a consumer and describes the occurrence of ADNEXA UTERI PAIN (Pain in my left ovary which is chronic and getting worse), PRURITUS (Itchy arm for a week) and FATIGUE (Fatigue for a month) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADNEXA UTERI PAIN (Pain in my left ovary which is chronic and getting worse), PRURITUS (Itchy arm for a week) and FATIGUE (Fatigue for a month). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at a dose of 1 dosage form. At the time of the report, ADNEXA UTERI PAIN (Pain in my left ovary which is chronic and getting worse) had not resolved and PRURITUS (Itchy arm for a week) and FATIGUE (Fatigue for a month) outcome was unknown.            No concomitant medication information was provided.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ometime between 32 to 36 hours passed from when the vial was opened until it was administered to this patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (ometime between 32 to 36 hours passed from when the vial was opened until it was administered to this patient) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (ometime between 32 to 36 hours passed from when the vial was opened until it was administered to this patient). On 04-Aug-2021, EXPIRED PRODUCT ADMINISTERED (ometime between 32 to 36 hours passed from when the vial was opened until it was administered to this patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications information was not reported. Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Followup received  provided no new information.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered from an expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered from an expired vial) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered from an expired vial). On 04-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered from an expired vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment information was reported.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: My arm was sore at the injection site.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (My arm was sore at the injection site.) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.  On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (My arm was sore at the injection site.). At the time of the report, VACCINATION SITE PAIN (My arm was sore at the injection site.) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications were reported. No treatment related information was reported.   This case was linked to MOD-2021-278957 (Patient Link).
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: My arm was sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (My arm was sore at the injection site) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE PAIN (My arm was sore at the injection site). At the time of the report, INJECTION SITE PAIN (My arm was sore at the injection site) outcome was unknown.            No concomitant medications were reported.   No treatment medications were reported.   This case was linked to MOD-2021-278948 (Patient Link).   Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: after first dose constant itch is completely gone; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (after first dose constant itch is completely gone) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Depression, Sleep problem, Itching all over (doctor called "senior itch") and Feeling abnormal (Miserable).    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (after first dose constant itch is completely gone). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (after first dose constant itch is completely gone) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 01-Mar-2021 patient took second dose in the right arm, batch number-011A21A. The patient confirms not experiencing any negative symptoms after receiving either dose. The patient reported that she constant itch completely resolved after receiving the first dose.   No concomitant medications information was reported.  No treatment details were provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia, Swelling, Vaccination site pain
Clinical narrative: Patient is swollen; Still having some pain in the exact spot where the shot is; Had sore arm for a while/Patient is sore; Swollen lymph nodes in her left arm, under her armpit, over the left breast, over the clavicle; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Patient is swollen), VACCINATION SITE PAIN (Still having some pain in the exact spot where the shot is), MYALGIA (Had sore arm for a while/Patient is sore) and LYMPHADENOPATHY (Swollen lymph nodes in her left arm, under her armpit, over the left breast, over the clavicle) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 020B21A) for COVID-19 vaccination.     Concomitant products included METFORMIN, LISINOPRIL, NAPROXEN and ASCORBIC ACID, ZINC (VITAMIN C) for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced SWELLING (Patient is swollen), VACCINATION SITE PAIN (Still having some pain in the exact spot where the shot is), MYALGIA (Had sore arm for a while/Patient is sore) and LYMPHADENOPATHY (Swollen lymph nodes in her left arm, under her armpit, over the left breast, over the clavicle). At the time of the report, SWELLING (Patient is swollen), MYALGIA (Had sore arm for a while/Patient is sore) and LYMPHADENOPATHY (Swollen lymph nodes in her left arm, under her armpit, over the left breast, over the clavicle) outcome was unknown and VACCINATION SITE PAIN (Still having some pain in the exact spot where the shot is) had not resolved.            No treatment medications were reported   This case was linked to MOD-2021-278974 (Patient Link).
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Confusional state, Discomfort, Feeling abnormal, Headache
Clinical narrative: feeling anxious/ like a wave of anxiety; confusion; brain fog; uneasiness; headaches; bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.; light pink or white welts; These were light pink or white welts; arm swelled; red rash (arm); tenderness at the injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)), ANXIETY (feeling anxious/ like a wave of anxiety), SKIN DISCOLOURATION (These were light pink or white welts) and DISCOMFORT (uneasiness) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)) and VACCINATION SITE PAIN (tenderness at the injection). On 03-Aug-2021, the patient experienced SKIN DISCOLOURATION (These were light pink or white welts), PRURITUS (bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.) and URTICARIA (light pink or white welts). On 04-Aug-2021, the patient experienced ANXIETY (feeling anxious/ like a wave of anxiety), DISCOMFORT (uneasiness), CONFUSIONAL STATE (confusion), FEELING ABNORMAL (brain fog) and HEADACHE (headaches). On 04-Aug-2021, PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)), ANXIETY (feeling anxious/ like a wave of anxiety), DISCOMFORT (uneasiness), CONFUSIONAL STATE (confusion), FEELING ABNORMAL (brain fog), VACCINATION SITE PAIN (tenderness at the injection) and HEADACHE (headaches) had resolved. At the time of the report, SKIN DISCOLOURATION (These were light pink or white welts), PRURITUS (bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.) and URTICARIA (light pink or white welts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter. No treatment information was provided by the reporter.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Rash erythematous, Skin discolouration, Urticaria
Clinical narrative: feeling anxious/ like a wave of anxiety; confusion; brain fog; uneasiness; headaches; bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.; light pink or white welts; These were light pink or white welts; arm swelled; red rash (arm); tenderness at the injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)), ANXIETY (feeling anxious/ like a wave of anxiety), SKIN DISCOLOURATION (These were light pink or white welts) and DISCOMFORT (uneasiness) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)) and VACCINATION SITE PAIN (tenderness at the injection). On 03-Aug-2021, the patient experienced SKIN DISCOLOURATION (These were light pink or white welts), PRURITUS (bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.) and URTICARIA (light pink or white welts). On 04-Aug-2021, the patient experienced ANXIETY (feeling anxious/ like a wave of anxiety), DISCOMFORT (uneasiness), CONFUSIONAL STATE (confusion), FEELING ABNORMAL (brain fog) and HEADACHE (headaches). On 04-Aug-2021, PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)), ANXIETY (feeling anxious/ like a wave of anxiety), DISCOMFORT (uneasiness), CONFUSIONAL STATE (confusion), FEELING ABNORMAL (brain fog), VACCINATION SITE PAIN (tenderness at the injection) and HEADACHE (headaches) had resolved. At the time of the report, SKIN DISCOLOURATION (These were light pink or white welts), PRURITUS (bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.) and URTICARIA (light pink or white welts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter. No treatment information was provided by the reporter.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: feeling anxious/ like a wave of anxiety; confusion; brain fog; uneasiness; headaches; bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.; light pink or white welts; These were light pink or white welts; arm swelled; red rash (arm); tenderness at the injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)), ANXIETY (feeling anxious/ like a wave of anxiety), SKIN DISCOLOURATION (These were light pink or white welts) and DISCOMFORT (uneasiness) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)) and VACCINATION SITE PAIN (tenderness at the injection). On 03-Aug-2021, the patient experienced SKIN DISCOLOURATION (These were light pink or white welts), PRURITUS (bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.) and URTICARIA (light pink or white welts). On 04-Aug-2021, the patient experienced ANXIETY (feeling anxious/ like a wave of anxiety), DISCOMFORT (uneasiness), CONFUSIONAL STATE (confusion), FEELING ABNORMAL (brain fog) and HEADACHE (headaches). On 04-Aug-2021, PERIPHERAL SWELLING (arm swelled), RASH ERYTHEMATOUS (red rash (arm)), ANXIETY (feeling anxious/ like a wave of anxiety), DISCOMFORT (uneasiness), CONFUSIONAL STATE (confusion), FEELING ABNORMAL (brain fog), VACCINATION SITE PAIN (tenderness at the injection) and HEADACHE (headaches) had resolved. At the time of the report, SKIN DISCOLOURATION (These were light pink or white welts), PRURITUS (bumps and itchiness on my back, sides, and stomach./The itchiness was worse with pressure, around her bra and waistline and while showering, and with sleep.) and URTICARIA (light pink or white welts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter. No treatment information was provided by the reporter.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: A patient received three doses of the Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of OFF LABEL USE (A patient received three doses of the Moderna COVID-19 vaccine) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048C21A, 003B21A and 032M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Aug-2021, the patient experienced OFF LABEL USE (A patient received three doses of the Moderna COVID-19 vaccine). On 04-Aug-2021, OFF LABEL USE (A patient received three doses of the Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant medications were provided.  Action taken with mRNA-1273 in response to the event was not applicable.  The nurse practitioner explained that the patient lied and or misrepresented having received the Moderna COVID-19 vaccine earlier at another facility, but her medical records indicate that he did indeed receive a total of 3 doses.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received  and it contains no new information On 30-Sep-2021: Follow up received on 01 oct 2021 contains non- significant information .
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Feeling crappy too; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling crappy too) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Feeling crappy too). At the time of the report, MALAISE (Feeling crappy too) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were reported.  The patient did not clarify if the patient received Moderna COVID-19 Vaccine. The patient was in close proximity with a positive case of COVID.   This case was linked to US-MODERNATX, INC.-MOD-2021-126915 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-126915:(MOD-2021-126915) The reporter from same case reported that a relative was feeling crappy too
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site mass, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Vaccination adverse reaction; bump on injection site; ITCH; it is getting larger and has a rash; It is tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction), VACCINATION SITE MASS (bump on injection site), VACCINATION SITE PRURITUS (ITCH), VACCINATION SITE RASH (it is getting larger and has a rash) and VACCINATION SITE PAIN (It is tender) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 010M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D3 from January 2020 to an unknown date and CALCIUM from January 2000 to an unknown date for Bone disorder (NOS), ASCORBIC ACID, BETACAROTENE, COPPER, NICOTINAMIDE, SELENIUM, TOCOPHEROL, XANTOFYL, ZINC (LUTEIN +) from January 2009 to an unknown date for Eye abnormality NOS, HYDROCHLOROTHIAZIDE from January 2005 to an unknown date for Heart disease, unspecified, METOPROLOL from January 2005 to an unknown date for Heart disorder.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). an unknown date, the patient experienced VACCINATION SITE MASS (bump on injection site) and VACCINATION SITE PAIN (It is tender). an unknown date, the patient experienced VACCINATION SITE PRURITUS (ITCH) and VACCINATION SITE RASH (it is getting larger and has a rash). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction), VACCINATION SITE MASS (bump on injection site) and VACCINATION SITE RASH (it is getting larger and has a rash) had resolved and VACCINATION SITE PRURITUS (ITCH) and VACCINATION SITE PAIN (It is tender) outcome was unknown.            The treatment information was unknown.   This case was linked to MOD-2021-026743 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: After the 4th day of receiving the vaccine she had chest pain, it went away; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (After the 4th day of receiving the vaccine she had chest pain, it went away) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart murmur (heart murmur from birth).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (After the 4th day of receiving the vaccine she had chest pain, it went away). At the time of the report, CHEST PAIN (After the 4th day of receiving the vaccine she had chest pain, it went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported. On 06-Aug-2021, the patient was due for the second dose.
Sex: U
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: Unknown number of patients received doses from 9 vials that had went through a temperature excursion; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Unknown number of patients received doses from 9 vials that had went through a temperature excursion) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Unknown number of patients received doses from 9 vials that had went through a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Unknown number of patients received doses from 9 vials that had went through a temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Pain, Vaccination site pain
Clinical narrative: pain; pain; numbness; weakness; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (pain), VACCINATION SITE PAIN (pain), HYPOAESTHESIA (numbness) and ASTHENIA (weakness) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced PAIN (pain), VACCINATION SITE PAIN (pain), HYPOAESTHESIA (numbness) and ASTHENIA (weakness). At the time of the report, PAIN (pain), VACCINATION SITE PAIN (pain), HYPOAESTHESIA (numbness) and ASTHENIA (weakness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided. Patient race was reported as black.   This case was linked to MOD-2021-252806 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sick for 3-4 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick for 3-4 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick for 3-4 days). At the time of the report, ILLNESS (Sick for 3-4 days) outcome was unknown.            No concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: gone longer than two months between injections; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (gone longer than two months between injections) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (gone longer than two months between injections). On 06-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (gone longer than two months between injections) had resolved.            No concomitant medications information was reported. No treatment medications were provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Headache, Myalgia
Clinical narrative: diarrhea, very loose stool in the mornings; joint pain; muscle ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea, very loose stool in the mornings), ARTHRALGIA (joint pain), MYALGIA (muscle ache) and HEADACHE (headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059E21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced ARTHRALGIA (joint pain), MYALGIA (muscle ache) and HEADACHE (headache). On 30-Jul-2021, the patient experienced DIARRHOEA (diarrhea, very loose stool in the mornings). The patient was treated with PROBIOTICS NOS for Diarrhea, at an unspecified dose and frequency and BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Diarrhea, at a dose of UNK dosage form. On 30-Jul-2021, ARTHRALGIA (joint pain), MYALGIA (muscle ache) and HEADACHE (headache) had resolved. At the time of the report, DIARRHOEA (diarrhea, very loose stool in the mornings) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction to shot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction to shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction to shot). At the time of the report, HYPERSENSITIVITY (allergic reaction to shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Event occurred after 2nd vaccine; breakthrough case admission
Sex: U
Vaccine: COVID19
Symptoms: Limb discomfort, Vaccination site mass, Vaccination site pain, Vaccination site warmth
Clinical narrative: Large lump at injection site; Hot; Can barely lift arm; Hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Large lump at injection site), VACCINATION SITE WARMTH (Hot), LIMB DISCOMFORT (Can barely lift arm) and VACCINATION SITE PAIN (Hurts) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Large lump at injection site), VACCINATION SITE WARMTH (Hot), LIMB DISCOMFORT (Can barely lift arm) and VACCINATION SITE PAIN (Hurts). At the time of the report, VACCINATION SITE MASS (Large lump at injection site), VACCINATION SITE WARMTH (Hot), LIMB DISCOMFORT (Can barely lift arm) and VACCINATION SITE PAIN (Hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  No Treatment medication information was provided.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness, Chills, Coronary artery bypass, Haemorrhage, Headache
Clinical narrative: 1st, 2nd Local store, and 3rd booster local drugstore. Extreme headaches with loss of vision, ringing in both ears, fever, chills, muscle ache, nausea. Went to ER a few times for headache/vision loss and then on 2nd visit to ER had triple bypass in April, then 2 weeks later had blood loss that required a transfusion that I declined. Also having constant memory problems and shaking is worse than before vaccinations.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test, Memory impairment, Myalgia, Nausea, Pyrexia
Clinical narrative: 1st, 2nd Local store, and 3rd booster local drugstore. Extreme headaches with loss of vision, ringing in both ears, fever, chills, muscle ache, nausea. Went to ER a few times for headache/vision loss and then on 2nd visit to ER had triple bypass in April, then 2 weeks later had blood loss that required a transfusion that I declined. Also having constant memory problems and shaking is worse than before vaccinations.